Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Williams

Showing results (191-200 of 212) with videos related to

Pageof 22
Sort By:
Plos One|June 3, 2011
Cost-effectiveness of early treatment with first-line NNRTI-based HAART regimens in the UK, 1996-2006Eduard J Beck, Sundhiya Mandalia, Gary Lo, et al.
Plos One|January 7, 2011
Rising population cost for treating people living with HIV in the UK, 1997-2013Sundhiya Mandalia, Roshni Mandalia, Gary Lo, et al.
AIDS (London, England)|March 15, 2005
Long term probability of detection of HIV-1 drug resistance after starting antiretroviral therapy in routine clinical practiceAndrew N Phillips, David Dunn, Caroline Sabin, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 6, 2014
Distinct patterns of hepcidin and iron regulation during HIV-1, HBV, and HCV infectionsAndrew E Armitage, Andrea R Stacey, Eleni Giannoulatou, et al.
Circulation Research|August 12, 2021
Dach1 Extends Artery Networks and Protects Against Cardiac InjuryBrian Raftrey, Ian Williams, Pamela E Rios Coronado, et al.
Science Translational Medicine|September 9, 2016
Heat shock protein-based therapy as a potential candidate for treating the sphingolipidosesThomas Kirkegaard, James Gray, David A Priestman, et al.
European Heart Journal|July 19, 2021
Endocardial/endothelial angiocrines regulate cardiomyocyte development and maturation and induce features of ventricular non-compactionSiyeon Rhee, David T Paik, Johnson Y Yang, et al.
Scientific Reports|November 4, 2023
Natural killer cell responses during SARS-CoV-2 infection and vaccination in people living with HIV-1Aljawharah Alrubayyi, Emma Touizer, Dan Hameiri-Bowen, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 22, 2019
Contribution of proteasome-catalyzed peptide <i>cis</i>-splicing to viral targeting by CD8<sup>+</sup> T cells in HIV-1 infectionWayne Paes, German Leonov, Thomas Partridge, et al.
HIV Medicine|October 2, 2008
British HIV Association Guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008B G Gazzard, Jane Anderson, Abdel Babiker, et al.
Pageof 22

Showing results (191-200 of 212) with videos related to

Sort By:
Pageof 22
Plos One|June 3, 2011
Cost-effectiveness of early treatment with first-line NNRTI-based HAART regimens in the UK, 1996-2006Eduard J Beck, Sundhiya Mandalia, Gary Lo, et al.
Plos One|January 7, 2011
Rising population cost for treating people living with HIV in the UK, 1997-2013Sundhiya Mandalia, Roshni Mandalia, Gary Lo, et al.
AIDS (London, England)|March 15, 2005
Long term probability of detection of HIV-1 drug resistance after starting antiretroviral therapy in routine clinical practiceAndrew N Phillips, David Dunn, Caroline Sabin, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 6, 2014
Distinct patterns of hepcidin and iron regulation during HIV-1, HBV, and HCV infectionsAndrew E Armitage, Andrea R Stacey, Eleni Giannoulatou, et al.
Circulation Research|August 12, 2021
Dach1 Extends Artery Networks and Protects Against Cardiac InjuryBrian Raftrey, Ian Williams, Pamela E Rios Coronado, et al.
Science Translational Medicine|September 9, 2016
Heat shock protein-based therapy as a potential candidate for treating the sphingolipidosesThomas Kirkegaard, James Gray, David A Priestman, et al.
European Heart Journal|July 19, 2021
Endocardial/endothelial angiocrines regulate cardiomyocyte development and maturation and induce features of ventricular non-compactionSiyeon Rhee, David T Paik, Johnson Y Yang, et al.
Scientific Reports|November 4, 2023
Natural killer cell responses during SARS-CoV-2 infection and vaccination in people living with HIV-1Aljawharah Alrubayyi, Emma Touizer, Dan Hameiri-Bowen, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 22, 2019
Contribution of proteasome-catalyzed peptide <i>cis</i>-splicing to viral targeting by CD8<sup>+</sup> T cells in HIV-1 infectionWayne Paes, German Leonov, Thomas Partridge, et al.
HIV Medicine|October 2, 2008
British HIV Association Guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008B G Gazzard, Jane Anderson, Abdel Babiker, et al.
Pageof 22